Global Latent Tuberculosis Infection Detection Market Size, Share, Trends & Growth Analysis Report 2026-2034

The global latent tuberculosis infection detection market size is expected to reach USD 4.08 Billion in 2034 from USD 2.40 Billion in 2025, growing at a CAGR of 6.08 during 2026-2034.This market is experiencing strong growth as healthcare organizations intensify efforts to identify latent tuberculosis infections before they progress to active disease. Early detection enables timely preventive treatment, helping reduce disease transmission and improve public health outcomes. Rising global tuberculosis control initiatives, increasing awareness of infectious disease prevention, and expanding healthcare screening programs are driving greater adoption of advanced diagnostic technologies across developed and emerging regions.

Healthcare providers are increasingly utilizing interferon-gamma release assays, tuberculin skin tests, and advanced laboratory diagnostics to improve screening accuracy and efficiency. Technological advancements in immunological testing, automation, and digital laboratory systems are enhancing diagnostic performance while reducing turnaround times. Government investments in tuberculosis elimination programs and international public health collaborations continue supporting market expansion. Growing focus on high-risk populations further strengthens demand.

The future outlook remains highly favorable as global healthcare systems prioritize infectious disease prevention and early intervention. Portable diagnostic platforms, artificial intelligence-assisted laboratory analysis, and improved biomarker research will enhance screening capabilities and accessibility. Expansion of healthcare infrastructure and continued investment in tuberculosis research will create significant opportunities. Ongoing innovation in diagnostic technologies will support long-term growth and contribute to global tuberculosis control efforts.

Our reports are carefully developed to deliver comprehensive and actionable insights across a wide range of industries and markets. Each report includes several essential components designed to provide a complete understanding of the market environment:

Market Overview: This section provides a clear introduction to the market, including key definitions, classifications, and an overview of the current industry landscape.

Market Dynamics: A detailed evaluation of the primary drivers, restraints, opportunities, and challenges shaping market growth. It covers factors such as technological developments, regulatory frameworks, and evolving industry trends.

Segmentation Analysis: A structured breakdown of the market into key segments based on product type, application, end-user, and geographic region. This section highlights the performance, growth potential, and contribution of each segment.

Competitive Landscape: An in-depth assessment of leading market participants, including their market positioning, product portfolios, strategic initiatives, and financial performance. It provides valuable insights into competitive dynamics and the strategies adopted by key players.

Market Forecast: Data-driven projections of market size and growth patterns over a defined forecast period. This section incorporates historical trends, current market conditions, and quantitative analysis to illustrate expected future developments.

Regional Analysis: A comprehensive review of market performance across major geographic regions, identifying high-growth areas and regional trends to better understand localized market opportunities.

Emerging Trends and Opportunities: Identification of significant market trends, technological advancements, and new investment opportunities. This section highlights potential growth areas and future industry developments.

Customization Options: We offer flexible customization services to tailor reports according to specific client requirements. This may include additional segmentation, country-level analysis, competitor profiling, customized data points, or focused insights on particular market segments to better support strategic decision-making.

MARKET SEGMENTATION

By Brand

• QFT-Plus (QuantiFERON-TB Gold Plus)
• Others

By Test

• Tuberculin Skin Test (TST)
• Interferon Gamma Release Assay (IGRA)

By Application

• Household Contacts with Pulmonary TB
• People Living with HIV (PLHIV)
• Others

By End Use

• Diagnostic Laboratories
• Hospitals/Clinics
• Academic & Research Institutions

COMPANIES PROFILED

• QIAGEN, bioMerieux, Oxford Immunotec, SD Biosensor Inc., Wantai BioPharm, Lionex GmbH, Serum Institute of India, ARKRAY Inc., F. Hoffmann-La Roche, Abbott Laboratories, Siemens Healthineers, Danaher Corporation (Cepheid), Thermo Fisher Scientific, Bio-Rad Laboratories, Hologic, Revvity Inc., Fujirebio Holdings, Mylab Discovery Solutions